查看文章

The impact of a collaborative, employer-sponsored diabetes management program on glycemic control and other clinical endpoints over 6–12 months is reported.

In a retrospective, chart-based evaluation, glycosylated hemoglobin (HbA_1c) and related health status indicators were assessed among first-year enrollees in the Healthy Outcome Partnership for Employees (HOPE) with Diabetes Program, an ongoing program sponsored by the Wake Forest Baptist Health (WFBH) system. Diabetes management services were provided by pharmacists in collaboration with providers inside and outside the WFBH system. The primary endpoint was the mean change in HbA_1c during follow-up averaging 8.2 months; secondary endpoints included changes in blood pressure, cholesterol, and triglyceride levels.

Among the 98 patients included …